Merck (MRK) Tops Q3 EPS by 7c, Raises Dividend and Increases Buyback by $10 Billion

Merck (NYSE: MRK) reported Q3 EPS of $1.19, $0.07 better than the analyst estimate of $1.12. Revenue for the quarter came in at $10.8 billion versus the consensus estimate of $10.88 billion.

GUIDANCE:

Merck sees FY2018 EPS of $4.30-$4.36, versus the consensus of $4.29. Revenue is expected to be $42.1-$42.7 billion vs $42.46 billion expected.

Company Announces 15 Percent Increase to Quarterly Dividend to 55 Cents Per Outstanding Share and Authorizes an Additional $10 Billion Share Repurchase, Including a $5 Billion Accelerated Share Repurchase Program

For earnings history and earnings-related data on Merck (MRK) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Mesa Laboratories (MLAB) Declares $0.16 Quarterly Dividend; 0.6% Yield
• Third Coast Bancshares approves $30M share repurchase program